Investigative needle core biopsies for multi-omics in Glioblastoma
Yu, K. K.; Basu, S.; Bacquer, G.; Ahn, R.; Gantchev, J.; Jindal, S.; Regan, M. S.; Abou-Mrad, Z.; Prabhu, M. C.; Williams, M. J.; D'Souza, A. D.; Malinowski, S. W.; Hopland, K.; Elhanati, Y.; Stopka, S. A.; Stortchevoi, A.; He, Z.; Sun, J.; Chen, Y.; Espejo, A.; Chow, K. H.; Yerrum, S.; Kao, P.-L.; Parker Kerrigan, B.; Norberg, L.; Nielsen, D.; Puduvalli, V. K.; Huse, J.; Beroukhim, R.; Kim, Y. S. B.; Goswami, S.; Boire, A.; Frisken, S.; Cima, M. J.; Holdoff, M.; Lucas, C.-H. G.; Bettegowda, C.; Levine, S. S.; Bale, T. A.; Brennan, C.; Reardon, D. A.; Lang, F. F.; Chiocca, E. A.; Ligon, K. L.;
Show abstract
Glioblastoma (GBM) is a primary brain cancer with an abysmal prognosis and few effective therapies. The ability to investigate the tumor microenvironment before and during treatment would greatly enhance both understanding of disease response and progression, as well as the delivery and impact of therapeutics. Stereotactic biopsies are a routine surgical procedure performed primarily for diagnostic histopathologic purposes. The role of investigative biopsies - tissue sampling for the purpose of understanding tumor microenvironmental responses to treatment using integrated multi-modal molecular analyses ( Multi-omics") has yet to be defined. Secondly, it is unknown whether comparatively small tissue samples from brain biopsies can yield sufficient information with such methods. Here we adapt stereotactic needle core biopsy tissue in two separate patients. In the first patient with recurrent GBM we performed highly resolved multi-omics analysis methods including single cell RNA sequencing, spatial-transcriptomics, metabolomics, proteomics, phosphoproteomics, T-cell clonotype analysis, and MHC Class I immunopeptidomics from biopsy tissue that was obtained from a single procedure. In a second patient we analyzed multi-regional core biopsies to decipher spatial and genomic variance. We also investigated the utility of stereotactic biopsies as a method for generating patient derived xenograft models in a separate patient cohort. Dataset integration across modalities showed good correspondence between spatial modalities, highlighted immune cell associated metabolic pathways and revealed poor correlation between RNA expression and the tumor MHC Class I immunopeptidome. In conclusion, stereotactic needle biopsy cores are of sufficient quality to generate multi-omics data, provide data rich insight into a patients disease process and tumor immune microenvironment and can be of value in evaluating treatment responses. One sentence summaryIntegrative multi-omics analysis of stereotactic needle core biopsies in glioblastoma
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Tumor cell-derived spermidine promotes a pro-tumorigenic immune microenvironment in glioblastoma via CD8+ T cell inhibition 96%
- SLIT2-ROBO signaling in tumor-associated microglia/macrophages drives glioblastoma immunosuppression and vascular dysmorphia 95%
- IL-7-mediated expansion of autologous lymphocytes increases CD8+ VLA-4 expression and accumulation in glioblastoma models 94%
Similar papers in this journal
- Remote Neuroinflammation in Newly Diagnosed Glioblastoma Correlates with Unfavorable Clinical Outcome 95%
- Preclinical modeling of surgery and steroid therapy for glioblastoma reveals changes in immunophenotype that are associated with tumor growth and outcome 94%
- Myeloid cell-associated resistance to PD-1/PD-L1 blockade in urothelial cancer revealed through bulk and single-cell RNA sequencing 93%
Similar papers in this journal
- High risk glioblastoma cells revealed by machine learning and single cell signaling profiles 95%
- Multi-omic Characterization of Pancreatic Cancer-Associated Macrophage Polarization Reveals Deregulated Metabolic Programs Driven by the GMCSF-PI3K Pathway 94%
- NAB2-STAT6 drives an EGR1-dependent neuroendocrine program in Solitary Fibrous Tumors 93%
Similar papers in this journal
- An engineered glioblastoma model yields novel macrophage-secreted drivers of invasion 94%
- Hypoxia-induced Complement Component 3 Promotes Aggressive Tumor Growth in the Glioblastoma Microenvironment 94%
- Enhancing CAR-T Cell Metabolism to Overcome Hypoxic Conditions in the Brain Tumor Microenvironment 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.